By ThinkSabio #ThinkSabio US Market Morning Brief
US MARKET MORNING BRIEF
Pre-Market Gainers
- RDFN +75% Rocket Companies to Acquire Redfin, Accelerating Purchase Mortgage Strategy
- CKPT +66% India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln (March 09)
- MLYS +63% Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension
Pre-Market Decliners:
- CRKN -33% Crown Receives Nasdaq Delisting Determination and Plans to Request Reconsideration
- ABLV -22%
Pre-Market Penny Gainers:
- STSS +70% STSS CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary (March 06)
- IBG+18%
Headlines
BEAM Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (#AATD), Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation.